Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Buchanan

Showing results (501-510 of 519) with videos related to

Pageof 52
Sort By:
Journal of Medicinal Chemistry|June 4, 2011
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent painHoward Bregman, Loren Berry, John L Buchanan, et al.
Journal of Medicinal Chemistry|August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonistsYuan Cheng, Brian K Albrecht, James Brown, et al.
Molecular Ecology|November 7, 2023
Concurrent invasions of European starlings in Australia and North America reveal population-specific differentiation in shared genomic regionsNatalie R Hofmeister, Katarina C Stuart, Wesley C Warren, et al.
Pediatric Research|October 14, 2021
Genetic determinants of metabolic biomarkers and their associations with cardiometabolic traits in Hispanic/Latino adolescentsDaeeun Kim, Anne E Justice, Geetha Chittoor, et al.
Journal of Medicinal Chemistry|December 4, 2013
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitorsZihao Hua, Howard Bregman, John L Buchanan, et al.
Trends in Ecology & Evolution|February 2, 2019
Extreme Competence: Keystone Hosts of InfectionsLynn B Martin, BriAnne Addison, Andrew G D Bean, et al.
Circulation. Genomic and Precision Medicine|April 27, 2026
Integrated Genomic and Transcriptomic Study Reveals <i>MAPK11</i> and <i>PER1</i> as Important Obesity Susceptibility Genes in a High-Risk Hispanic/Latino PopulationDaeeun Kim, Hannah G Polikowsky, Heather M Highland, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 23, 2018
Metrics of progress in the understanding and management of threats to Australian birdsS T Garnett, S H M Butchart, G B Baker, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2011
Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitorsJohn L Buchanan, John R Newcomb, David P Carney, et al.
Genome Medicine|October 7, 2025
Genetic underpinnings of the heterogeneous impact of obesity on lipid levels and cardiovascular diseaseDaeeun Kim, Heather M Highland, Roelof A J Smit, et al.
Pageof 52

Showing results (501-510 of 519) with videos related to

Sort By:
Pageof 52
Journal of Medicinal Chemistry|June 4, 2011
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent painHoward Bregman, Loren Berry, John L Buchanan, et al.
Journal of Medicinal Chemistry|August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonistsYuan Cheng, Brian K Albrecht, James Brown, et al.
Molecular Ecology|November 7, 2023
Concurrent invasions of European starlings in Australia and North America reveal population-specific differentiation in shared genomic regionsNatalie R Hofmeister, Katarina C Stuart, Wesley C Warren, et al.
Pediatric Research|October 14, 2021
Genetic determinants of metabolic biomarkers and their associations with cardiometabolic traits in Hispanic/Latino adolescentsDaeeun Kim, Anne E Justice, Geetha Chittoor, et al.
Journal of Medicinal Chemistry|December 4, 2013
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitorsZihao Hua, Howard Bregman, John L Buchanan, et al.
Trends in Ecology & Evolution|February 2, 2019
Extreme Competence: Keystone Hosts of InfectionsLynn B Martin, BriAnne Addison, Andrew G D Bean, et al.
Circulation. Genomic and Precision Medicine|April 27, 2026
Integrated Genomic and Transcriptomic Study Reveals <i>MAPK11</i> and <i>PER1</i> as Important Obesity Susceptibility Genes in a High-Risk Hispanic/Latino PopulationDaeeun Kim, Hannah G Polikowsky, Heather M Highland, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 23, 2018
Metrics of progress in the understanding and management of threats to Australian birdsS T Garnett, S H M Butchart, G B Baker, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2011
Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitorsJohn L Buchanan, John R Newcomb, David P Carney, et al.
Genome Medicine|October 7, 2025
Genetic underpinnings of the heterogeneous impact of obesity on lipid levels and cardiovascular diseaseDaeeun Kim, Heather M Highland, Roelof A J Smit, et al.
Pageof 52